Location: Home
  • search
  • go
  • Relate News
  • 2/15/2022Lacking Revenue, Lepu Biopharma Chases IPO to Revive War Chest (The Ba...
  • 2/14/2022Chinese Drug Developers Look to Enter the U.S. Market through Out-lice...
  • 2/14/2022Bloomberg: China's Approval of Pfizer Pill Opens Door to Ending Its 'C...
  • 2/14/2022Takeda Vows to Expand Business and Investments in China
  • 2/14/2022Chinese CDMO Asymchem to Expand in the U.S. thru Acquisition of Snapdr...
  • 2/14/2022NHC Reorganizes, Integrating Relevant Jurisdictions and Departments wi...
  • 2/13/2022China Approves Pfizer's Covid Drug Paxlovid Conditionally
  • 2/13/2022State Council's Policy Briefing Confirms Accelerated Expansion of Cent...
  • 2/13/2022Innovent's Setback Warns Peers Prioritizing Pricing Not Good Tactic in...
  • 2/11/2022EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immu...
  • 2/11/2022AKSO and Huadong Medicine Enter Strategic Collaboration to Develop/Com...
  • 2/11/2022NMPA Issues the List of Reference Formulations for GQCE Studies (51st ...
  • 2/11/2022Drug R&D and Product Registration News Digest February 2022 (1)
  • 2/10/2022AstraZeneca Reports Q4 and FY 2021 Performance, China Revenue Surging ...
  • 2/10/2022CDE Issues the Q&As on Issues Related to Pharmaceutical Research and E...
  • 2/10/2022GSK Won Chinese Approval of Benlysta (belimumab) for Adult Patients wi...
  • 2/10/2022U.S. FDA Panel Recommends Additional Trial for Lilly/Innovent Lung Ca...
  • 2/10/2022China Is the Focus of AZ's Earnings Call for Q4 and FY 2021, BMI Fraud...
  • 2/10/2022CDE issues the Technical Guidelines for Clinical Pharmacology Study of...
  • 2/10/2022Why the FDA Is Making a Test Case of a Cancer Drug from China
  • 2/10/2022China Encourages Real-world Data, Cell and Gene Therapy in Shenzhen (P...
  • 2/9/2022CDE Solicits Comments on the Draft Guidelines for Acceptance and Evalu...
  • 2/9/2022Lepu Biopharma Announces Proposed Public Listing in Hong Kong
  • 2/9/2022GSK Reports Q4 and FY2021 Performance with China Related Mentions
  • 2/9/2022Zerun Bio and Walvax to Get Additional CEPI Funding for Vaccine to Pro...
  • 2/8/2022USPTO Webinar: Biopharma Patents in China: Litigation, Licensing, and ...
  • 2/8/2022Sanofi Reports Slowing Chinese Growth in Q4/2021
  • 2/8/2022MSD's China Sales Skyrocketed Driven by Strong HPV Vaccine Growth
  • 2/8/2022Novartis China Witness 10% Innovative Medicine Sales Growth in 2021 De...
  • 2/8/2022EdiGene and Arbor Biotechnologies Announce Worldwide Non-exclusive Lic...
  • Page:94/719 Total number of articles:21546: [First][<<] [92] [93] [94] [95] [96] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group